PAROLARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 14.034
EU - Europa 8.230
AS - Asia 3.967
SA - Sud America 573
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
Totale 26.876
Nazione #
US - Stati Uniti d'America 13.895
IT - Italia 4.137
UA - Ucraina 1.456
SG - Singapore 1.397
SE - Svezia 772
CN - Cina 664
TR - Turchia 631
VN - Vietnam 523
HK - Hong Kong 506
BR - Brasile 496
FI - Finlandia 380
IE - Irlanda 356
DE - Germania 351
GB - Regno Unito 273
RU - Federazione Russa 189
FR - Francia 106
CA - Canada 77
IN - India 59
JP - Giappone 55
MX - Messico 47
NL - Olanda 35
PL - Polonia 32
BD - Bangladesh 31
BE - Belgio 30
CZ - Repubblica Ceca 24
AR - Argentina 23
ZA - Sudafrica 23
ES - Italia 21
IQ - Iraq 17
AT - Austria 15
EU - Europa 15
VE - Venezuela 11
CO - Colombia 10
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
EC - Ecuador 9
LT - Lituania 9
MA - Marocco 9
BG - Bulgaria 7
IL - Israele 7
MY - Malesia 7
NP - Nepal 7
AU - Australia 6
JO - Giordania 6
SA - Arabia Saudita 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
PT - Portogallo 5
UY - Uruguay 5
UZ - Uzbekistan 5
CH - Svizzera 4
EG - Egitto 4
ID - Indonesia 4
PY - Paraguay 4
AL - Albania 3
HU - Ungheria 3
KR - Corea 3
KZ - Kazakistan 3
MD - Moldavia 3
NG - Nigeria 3
PE - Perù 3
BO - Bolivia 2
CI - Costa d'Avorio 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 26.874
Città #
Milan 2.855
Fairfield 1.834
Ashburn 1.146
Woodbridge 1.128
Jacksonville 1.101
Chandler 1.089
Houston 839
Seattle 798
Singapore 779
Wilmington 728
Ann Arbor 659
Cambridge 607
Hong Kong 505
Dearborn 393
Princeton 380
Dublin 355
Izmir 352
Nyköping 349
Dallas 273
Rome 236
Boardman 224
Beijing 218
Dong Ket 218
Como 192
San Mateo 161
The Dalles 156
New York 155
Chicago 99
Los Angeles 90
San Diego 89
Ogden 61
Santa Clara 60
Washington 60
São Paulo 52
Tokyo 52
Hefei 50
London 49
Kunming 43
Munich 40
Norwalk 38
Ho Chi Minh City 36
Nanjing 34
Mexico City 33
Toronto 33
Warsaw 32
Brussels 30
Helsinki 29
Hanoi 24
Ponte Lambro 23
Brno 22
Brooklyn 22
Montreal 22
Orem 20
Nanchang 19
Phoenix 19
Verona 19
Atlanta 18
Denver 18
Guangzhou 18
Mcallen 18
Redwood City 18
Chennai 17
Kocaeli 17
Berlin 16
Düsseldorf 16
Johannesburg 16
Ankara 15
Jinan 15
Stockholm 15
Cagliari 14
Fuzhou 14
Poplar 14
Falls Church 13
Nuremberg 13
Carbonara Al Ticino 12
Edinburgh 12
Manchester 12
San Francisco 12
Amsterdam 11
Naples 11
Boston 10
Council Bluffs 10
Frankfurt am Main 10
San Jose 10
Shanghai 9
Belo Horizonte 8
Chengdu 8
Istanbul 8
Ottawa 8
Paris 8
Redmond 8
Salt Lake City 8
Salvador 8
Shenyang 8
Varese 8
Wuhan 8
Benevento 7
Bologna 7
Brasília 7
Chongqing 7
Totale 19.450
Nome #
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 296
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect 269
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats 265
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 254
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 249
Assay of GTPγS binding in autoradiography 247
Adolescent exposure to cannabis as a risk factor for psychiatric disorders 245
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 241
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine 239
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 235
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 230
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 224
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour 217
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol. 216
MeCP2 related studies benefit from the use of CD1 as genetic background 214
A molecular basis of analgesic tolerance to cannabinoids 213
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. 213
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 210
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 209
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. 207
New vistas on cannabis use disorder 205
Long lasting consequences of cannabis exposure in adolescence. 204
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi 201
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling 199
Endocannabinoids and Mental Disorders. 198
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat 194
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats 194
Cannabinoids and opioids share cAMP pathway in rat splenocytes 192
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine 189
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring 188
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. 187
Role of endocannabinoids in regulating drug dependence 186
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor. 186
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 186
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 184
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT? 182
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche 181
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. 179
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. 175
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. 175
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 174
Cannabinoids and Drugs of abuse 173
Expression and function of the endocannabinoid system in glial cells. 172
Cellular mechanisms underlying the interaction between cannabinoid and opioid system 172
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 171
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. 171
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain 170
The endocannabinoid system and schizophrenia: integration of evidence. 169
Modulation of rat brain cannabinoid receptors after chronic morphine treatment 168
Endocannabinoids and Drug Dependence 167
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. 166
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain 163
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940 163
Molecular and cellular basis of cannabinoid and opioid interactions 163
Sex-dependent vulnerability to cannabis abuse in adolescence 163
Endocannabinoids in the immune system and cancer 162
The endocannabinoid system and psychiatric disorders. 162
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw 159
Neurobiological mechanisms underlying cannabis-induced memory impairment 157
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments 156
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects 155
The psychoactive ingredient of marijuana induces behavioural sensitization 153
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems 153
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats 153
Cannabidiol inhibits angiogenesis by multiple mechanisms 153
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade 152
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 152
A role of nitric oxide in WIN 55,212-2 tolerance in mice. 151
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure 150
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system 150
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system 148
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. 148
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. 146
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. 146
Presence and functional regulation of cannabinoid receptors in immune cells 145
Cholera toxin effects on body temperature changes induced by morphine. 145
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors 144
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat 143
Alterazioni cellulari e molecolari presenti nel sistema nervoso centrale durante i processi di sensitizzazione a lungo termine indotti da diversi farmaci d'abuso 142
Binding studies of dermorphin and its L-form on rat brain opioid receptors. 142
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages 141
Pertussis toxin inhibits the antinociceptive action of morphine in the rat.. 141
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats. 141
Presence of a reduced opioid response in interleukin-6 knock out mice 140
Cannabinoids as potential new therapy for the treatment of gliomas. 138
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat. 138
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze 138
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models 138
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization 137
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. 137
Alterazioni cellulari indotte da farmaci d'abuso e da stimoli avversivi non evitabili nel sistema nervoso centrale di ratto 134
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line 133
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. 133
Inhibition of tumor cell migration 133
Cannabinoids, immune system and cytokine network 132
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors 132
Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine.. 132
null 132
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells 131
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models 131
Totale 17.482
Categoria #
all - tutte 101.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.523


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.145 0 0 0 0 0 343 143 248 470 168 295 478
2021/20221.930 192 203 182 251 58 89 71 94 94 282 149 265
2022/20232.722 265 165 192 326 157 582 10 378 399 75 120 53
2023/20244.570 717 743 725 832 902 350 31 76 100 28 23 43
2024/20252.706 39 42 483 78 74 174 100 211 349 217 222 717
2025/20262.706 424 379 137 792 581 393 0 0 0 0 0 0
Totale 27.012